I get the whole benefit to science / the world, but can someone please explain the near-term commercial benefit to PYC in this move? Sure, I get they will improve their screening of candidates, etc.... but even though they get $4.5m up-front they have to spend $10m at a time where they are trying to do a lot and every $ is potentially very valuable. Maybe they have some insights into managing/sourcing capital that we haven't been told about yet, but is this the best priority for the limited $'s they have right now? Appreciate any insights.
I get the whole benefit to science / the world, but can someone...
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.003(3.09%) |
Mkt cap ! $466.6M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.5¢ | 9.8¢ | $150.1K | 1.503M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 666294 | 8 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
10.5¢ |
Change
0.003 ( 7.14 %) |
||||
| Open | High | Low | Volume | ||
| 10.0¢ | 10.5¢ | 9.7¢ | 826505 | ||
| Last updated 15.59pm 02/05/2024 ? | |||||
| PYC (ASX) Chart |